|By Marketwired .||
|May 23, 2014 08:00 AM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 05/23/14 -- BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that CEO Rene Goehrum will be making a presentation at the Marcum MicroCap Conference at 11am (ET), May 29, 2014 at the Grand Hyatt Hotel in New York City. Mr. Goehrum will provide an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting the Investor Center at the www.biosyent.com website or at the following conference link http://wsw.com/webcast/marcum2/bioyf. A replay of the webcast will be available for 90 days after the presentation date. The annual Marcum MicroCap Conference is a signature showcase for superior quality, under-followed public companies with less than $500 million in market capitalization.
Mr. Goehrum will be available for 1:1 meetings after his presentation.These meetings can be arranged via the conference organizers http://www.marcumllp.com/microcap.
To view and listen to the CEO presentation commenting on First Quarter 2014 Financial Results released May 16, 2014, please visit the following link http://www.biosyent.com/q1/.
For a direct market quote (15 minutes delay) for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.
About BioSyent Inc.
Listed on the Toronto Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth oriented specialty pharmaceutical company which searches the globe to in-license or acquire innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients and supporting the healthcare professionals that treat them.
Once a product of interest has been found, BioSyent then acquires the exclusive rights to the product and manages it through the Canadian governmental regulatory approval process. Once approved, BioSyent markets the product throughout Canada.
At the date of this press release the Company had 13,776,195 shares issued and outstanding.
Aug. 28, 2016 01:45 PM EDT Reads: 3,638
Aug. 28, 2016 01:00 PM EDT Reads: 2,406
Aug. 28, 2016 12:15 PM EDT Reads: 826
Aug. 28, 2016 11:45 AM EDT Reads: 654
Aug. 28, 2016 11:30 AM EDT Reads: 1,943
Aug. 28, 2016 11:00 AM EDT Reads: 3,113
Aug. 28, 2016 11:00 AM EDT Reads: 670
Aug. 28, 2016 10:45 AM EDT Reads: 820
Aug. 28, 2016 10:30 AM EDT Reads: 875
Aug. 28, 2016 10:30 AM EDT Reads: 4,018
Aug. 28, 2016 09:30 AM EDT Reads: 762
Aug. 28, 2016 09:30 AM EDT Reads: 709
Aug. 28, 2016 07:30 AM EDT Reads: 780
SYS-CON Events announced today that Isomorphic Software will exhibit at DevOps Summit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Isomorphic Software provides the SmartClient HTML5/AJAX platform, the most advanced technology for building rich, cutting-edge enterprise web applications for desktop and mobile. SmartClient combines the productivity and performance of traditional desktop software with the simp...
Aug. 28, 2016 03:30 AM EDT Reads: 2,366
With so much going on in this space you could be forgiven for thinking you were always working with yesterday’s technologies. So much change, so quickly. What do you do if you have to build a solution from the ground up that is expected to live in the field for at least 5-10 years? This is the challenge we faced when we looked to refresh our existing 10-year-old custom hardware stack to measure the fullness of trash cans and compactors.
Aug. 28, 2016 02:00 AM EDT Reads: 1,785